These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 22201475)

  • 1. Methods for assessing the preventability of adverse drug events: a systematic review.
    Hakkarainen KM; Andersson Sundell K; Petzold M; Hägg S
    Drug Saf; 2012 Feb; 35(2):105-26. PubMed ID: 22201475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of preventable adverse drug events: a review of the literature.
    von Laue NC; Schwappach DL; Koeck CM
    Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology.
    Hébert G; Netzer F; Kouakou SL; Lemare F; Minvielle E;
    Int J Clin Pharm; 2018 Apr; 40(2):376-385. PubMed ID: 29446003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A targeted method for standardized assessment of adverse drug events in surgical patients.
    de Boer M; Kiewiet JJ; Boeker EB; Ramrattan MA; Dijkgraaf MG; Lie-A-Huen L; Boermeester MA;
    J Eval Clin Pract; 2013 Dec; 19(6):1073-82. PubMed ID: 23593984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.
    Thomsen LA; Winterstein AG; Søndergaard B; Haugbølle LS; Melander A
    Ann Pharmacother; 2007 Sep; 41(9):1411-26. PubMed ID: 17666582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for evaluating adverse drug event preventability in emergency department patients.
    Woo SA; Cragg A; Wickham ME; Peddie D; Balka E; Scheuermeyer F; Villanyi D; Hohl CM
    BMC Med Res Methodol; 2018 Dec; 18(1):160. PubMed ID: 30514232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.
    Hakkarainen KM; Gyllensten H; Jönsson AK; Andersson Sundell K; Petzold M; Hägg S
    Br J Clin Pharmacol; 2014 Jul; 78(1):170-83. PubMed ID: 24372506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events and medication errors: detection and classification methods.
    Morimoto T; Gandhi TK; Seger AC; Hsieh TC; Bates DW
    Qual Saf Health Care; 2004 Aug; 13(4):306-14. PubMed ID: 15289635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.
    Kunac DL; Reith DM; Kennedy J; Austin NC; Williams SM
    Qual Saf Health Care; 2006 Jun; 15(3):196-201. PubMed ID: 16751470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
    Kunac DL; Kennedy J; Austin N; Reith D
    Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports.
    Winterstein AG; Hatton RC; Gonzalez-Rothi R; Johns TE; Segal R
    Am J Health Syst Pharm; 2002 Sep; 59(18):1742-9. PubMed ID: 12298112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-rater reliability of the assessment of adverse drug reactions in the hospitalised elderly.
    Tangiisuran B; Auyeung V; Cheek L; Rajkumar C; Davies G
    J Nutr Health Aging; 2013; 17(8):700-5. PubMed ID: 24097025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis.
    Hakkarainen KM; Hedna K; Petzold M; Hägg S
    PLoS One; 2012; 7(3):e33236. PubMed ID: 22438900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement and monitoring of surgical adverse events.
    Bruce J; Russell EM; Mollison J; Krukowski ZH
    Health Technol Assess; 2001; 5(22):1-194. PubMed ID: 11532239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The measurement of collaboration within healthcare settings: a systematic review of measurement properties of instruments.
    Walters SJ; Stern C; Robertson-Malt S
    JBI Database System Rev Implement Rep; 2016 Apr; 14(4):138-97. PubMed ID: 27532315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan.
    Iftikhar S; Sarwar MR; Saqib A; Sarfraz M
    PLoS One; 2018; 13(6):e0199456. PubMed ID: 29949616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature.
    Boeker EB; de Boer M; Kiewiet JJ; Lie-A-Huen L; Dijkgraaf MG; Boermeester MA
    BMC Health Serv Res; 2013 Sep; 13():364. PubMed ID: 24074346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of adverse drug events in ambulatory care: a systematic review.
    Taché SV; Sönnichsen A; Ashcroft DM
    Ann Pharmacother; 2011 Jul; 45(7-8):977-89. PubMed ID: 21693697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.